Browsing All of EconStor by Author Stargardt, Tom
Showing results 1 to 16 of 16
Year of Publication | Title | Author(s) |
2004 | Bürgerversicherung: Die Wirkung von Kopfprämien auf den Arbeitsmarkt | Farhauer, Oliver; Borchardt, Katja; Stargardt, Tom |
2005 | Defining benefit catalogues and entitlements to health care in Germany: Decision makers, decision criteria and taxonomy of catalogues | Busse, Reinhard; Stargardt, Tom; Schreyögg, Jonas; Simon, Claudia; Martin, Maria |
2011 | Effect of type of insurance and income on waiting time for outpatient care | Roll, Kathrin; Stargardt, Tom; Schreyögg, Jonas |
2012 | Measuring the relationship between costs and outcomes: The example of Acute Myocardial Infarction in German hospitals | Stargardt, Tom; Schreyögg, Jonas; Kondofersky, Ivan |
2020 | The impact of drug quality ratings from health technology assessments on the adoption of new drugs by physicians in Germany | Blankart, Katharina Elisabeth; Stargardt, Tom |
2020 | Cost–Utility of Internet-Based Cognitive Behavioral Therapy in Unipolar Depression: A Markov Model Simulation | Baumann, Mathias; Stargardt, Tom; Frey, Simon |
2020 | Impact of Guidelines on the Diffusion of Medical Technology: A Case Study of Cardiac Resynchronization Therapy in the UK | Vadia, Rucha; Stargardt, Tom |
2020 | Do discontinuities in marginal reimbursement affect inpatient psychiatric care in Germany? | Pott, Clara; Stargardt, Tom; Schneider, Udo; Frey, Simon |
2022 | Economic Effects of Fixed-Dose Versus Loose-Dose Combination Therapy for Type 2 Diabetes Patients | Böhm, Anna-Katharina; Schneider, Udo; Stargardt, Tom |
2022 | An econometric approach to aggregating multiple cardiovascular outcomes in German hospitals | Meggiolaro, Angela; Blankart, Carl Rudolf; Stargardt, Tom; Schreyögg, Jonas |
2022 | Does health technology assessment compromise access to pharmaceuticals? | Büssgen, Melanie; Stargardt, Tom |
2023 | Authors’ Reply to Gandjour: “10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?” | Büssgen, Melanie; Stargardt, Tom |
2023 | 10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany? | Büssgen, Melanie; Stargardt, Tom |
2023 | Does health technology assessment compromise access to pharmaceuticals? | Büssgen, Melanie; Stargardt, Tom |
2023 | Mapping from SIBDQ to EQ-5D-5L for patients with inflammatory bowel disease | Steiner, Isa Maria; Bokemeyer, Bernd; Stargardt, Tom |
2024 | The European COvid Survey (ECOS): Technical report | Sabat, Iryna; Neumann-Böhme, Sebastian; Stargardt, Tom; Schreyögg, Jonas |